Evaluating the costs of glycemic response with canagliflozin versus dapagliflozin and empagliflozin as add-on to metformin in patients with type 2 diabetes mellitus in the United Arab Emirates
Schubert, Agata, Buchholt, Anders T., El Khoury, Antoine C., Kamal, Ahmed, Taieb, VanessaLanguage:
english
Journal:
Current Medical Research and Opinion
DOI:
10.1080/03007995.2017.1310091
Date:
April, 2017
File:
PDF, 1.05 MB
english, 2017